Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer
2020 · Scientific Reports · 92 citations
https://doi.org/10.1038/s41598-020-71236-y
J
Josiane Lafleur
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
113
Papers
1.6K
Citations
23
h-index
31
i10-index
Josiane Lafleur is an academic researcher from Jewish General Hospital. The author has contributed to research in topics: Cancer Cells and Metastasis & Cancer, Hypoxia, and Metabolism & Cancer Genomics and Diagnostics. The author has an h-index of 23, co-authored 97 publications.
ORCID: 0000-0003-4459-8801Papers by this author
worksCurrent and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy
2023 · The American Journal of Human Genetics · 16 citations
https://doi.org/10.1016/j.ajhg.2023.08.014
“I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening
2023 · European Journal of Human Genetics · 5 citations
https://doi.org/10.1038/s41431-023-01473-y
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative
2025 · Cancer Cell · 2 citations
https://doi.org/10.1016/j.ccell.2025.03.014
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat